In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

MONDAY, Sept. 30, 2024 (HealthDay News) -- A synthetic form of the active ingredient in cannabis helps reduce agitation in ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

New research demonstrates that The Self-Administered Gerocognitive Exam (SAGE) can do exactly that. Here's everything you ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Monash University Neuroscientist Terence O’Brien said the disease “devastated” the lives of patients, but was often mistaken for depression, anxiety ... dementia cases but hoped their drug ...

The findings may provide encouragement for the families of the 7 million Americans who have Alzheimer's or another form of dementia ... other FDA-approved drug for agitation in this patient ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people ... meds might lower risk of dementia, Parkinson's Study finds Alzheimer's drugs might boost healthy protein ...